Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ranbaxy posts loss after write-offs on U.S. import bans
Reuters
Saturday, May 10, 2014 - 12:20pm
tags:
Ranbaxy, earnings
Teva sues FDA over bid to block approval of generic Copaxone
Live Mint
Saturday, May 10, 2014 - 12:17pm
tags:
Teva Pharmaceuticals, FDA, lawsuits, generics
RUTH SUNDERLAND: Why we must defend AstraZeneca from the £63bn takeover bid by Pfizer
This is Money, UK
Saturday, May 10, 2014 - 12:16pm
tags:
Pfizer, AstraZeneca, M&A
Plugging leaky blood vessels to save vision
Medical Xpress
Saturday, May 10, 2014 - 11:37am
tags:
sticky-trap
Pfizer’s Read Says AstraZeneca Deal Will Meet Scientific Needs
Bloomberg
Saturday, May 10, 2014 - 11:32am
tags:
Pfizer, AstraZeneca
Allergan Said to Be Rebuffed by Sanofi, J&J as It Seeks Bids
Bloomberg
Saturday, May 10, 2014 - 11:31am
tags:
Allergan, JNJ, Sanofi, M&A
Lilly Responds to Brazil Court Ruling in Labor Case
Yahoo/PR NewsWire
Saturday, May 10, 2014 - 10:52am
tags:
Eli Lilly, legal
Eli Lilly and Italian firm fined $450 mln for poisoning in Brazil
Reuters
Saturday, May 10, 2014 - 10:50am
tags:
Eli Lilly, legal
Amgen, AstraZeneca reports brodalumab study met primary, secondary endpoints
The Fly on the Wall
Saturday, May 10, 2014 - 10:48am
tags:
Amgen, AstraZeneca, brodalumab
Despite A Disappointing Performance, Pfizer Pins Its Hope On These Drugs
Seeking Alpha
Saturday, May 10, 2014 - 10:46am
tags:
Pfizer, Eliquis, Duavee, Nexium
NPS Pharmaceuticals' (NPSP) CEO Francois Nader on Q1 2014 Results - Earnings Call Transcript
Seeking Alpha
Saturday, May 10, 2014 - 10:41am
tags:
earnings, NPS Pharmaceuticals
Agenus' (AGEN) CEO Dr. Garo Armen on Q1 2014 Results - Earnings Call Transcript
Seeking Alpha
Saturday, May 10, 2014 - 10:38am
tags:
Agenus, earnings
Theravance Study Results Confirm in vitro Potency of VIBATIV(R) (telavancin) and Efficacy in Patients With Complicated Skin and Skin Structure Infections Including MRSA
Yahoo/MarketWired
Saturday, May 10, 2014 - 10:35am
tags:
MRSA, Vibativ, Theravance
Why Jazz Pharmaceuticals Inc. Shares Briefly Tumbled
Motley Fool
Saturday, May 10, 2014 - 10:34am
tags:
Jazz Pharmaceuticals
Gilead announces Phase 1 data for GS-6615
The Fly on the Wall
Saturday, May 10, 2014 - 10:32am
tags:
Gilead Sciences, GS-6615, long QT
Why Merck's Bayer Deal Makes Sense
Motley Fool
Friday, May 9, 2014 - 1:38pm
tags:
Merck, Bayer, consumer health, M&A
Britain Demands Stronger Commitments From Pfizer in AstraZeneca Deal
Wall St Cheat Sheet
Friday, May 9, 2014 - 12:33pm
tags:
UK, Pfizer, AstraZeneca
[video]Publicis CEO: Merger off as 'equality impossible'
CNBC
Friday, May 9, 2014 - 12:31pm
tags:
M&A, Publicis, Omnicom
Horizon Pharma Q1 Beats Street; Guidance Mixed
Investors.com
Friday, May 9, 2014 - 11:28am
tags:
Horizon Pharma, earnings
How Will Pfizer's (PFE) Stock Be Affected By Its Ongoing Battle for AstraZeneca (AZN)?
TheStreet.com
Friday, May 9, 2014 - 11:18am
tags:
Pfizer, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.